Concepedia

Kris Simon

KS

Statistics

Publications

8

Citations

364

H-Index

8

Active since

1984

Affiliations

University of Wisconsin–Madison(Current)

Kris Simon is an author at University of Wisconsin–Madison specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

1984–2004

8

Publications

8

Phase I study of taxol administered as a short i.v. infusion daily for 5 days.

Jean L. Grem, K D Tutsch, Kris Simon et al. · PubMed · 1987 · 102 citations

, , +10

Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion.

D L Trump, Jean L. Grem, K D Tutsch et al. · Journal of Clinical Oncology · 1987 · 57 citations

, , +12

A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.

Richard R. Love, Russell F. Jacoby, Michael A. Newton et al. · PubMed · 1998 · 51 citations

, , +17

Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.

James K. V. Willson, Paul H. Fischer, Kendra D. Tutsch et al. · PubMed · 1988 · 44 citations

, , +12

Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans.

Michael Hawkins, Ernest C. Borden, James A. Merritt et al. · Journal of Clinical Oncology · 1984 · 42 citations

, , +14

1–5 of 8